Lessons learned from the COVID-19 control strategy of the XXXII Tokyo Summer Olympics and the XXIV Beijing Winter Olympics
暂无分享,去创建一个
Wen Zhang | Yi Zhang | Jingwen Ai | Jing Bao
[1] C. Viboud,et al. Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China , 2022, BMC Medicine.
[2] Qiang Liu,et al. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost , 2021, Emerging microbes & infections.
[3] Liyuan Liu,et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 , 2021, Nature.
[4] C. Viboud,et al. Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021 , 2021, Nature Human Behaviour.
[5] M. Osterholm,et al. Protecting Olympic Participants from Covid-19 - The Urgent Need for a Risk-Management Approach. , 2021, The New England journal of medicine.
[6] R. Darnell,et al. Vaccine Breakthrough Infections with SARS-CoV-2 Variants , 2021, The New England journal of medicine.
[7] Nicola Perra,et al. Non-pharmaceutical interventions during the COVID-19 pandemic: A review , 2020, Physics Reports.
[8] J. Al-Tawfiq,et al. The Tokyo Olympic Games and the Risk of COVID-19 , 2020, Current Tropical Medicine Reports.
[9] M. C. Urban,et al. Seasonality and uncertainty in global COVID-19 growth rates , 2020, Proceedings of the National Academy of Sciences.
[10] G. Ippolito,et al. Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma , 2020, The Lancet.